Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genprex (GNPX) Liabilities and Shareholders Equity (2016 - 2025)

Genprex (GNPX) has 10 years of Liabilities and Shareholders Equity data on record, last reported at $3.6 million in Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity fell 8.82% year-over-year to $3.6 million; the TTM value through Sep 2025 reached $17.5 million, down 48.07%, while the annual FY2024 figure was $4.1 million, 61.35% down from the prior year.
  • Liabilities and Shareholders Equity reached $3.6 million in Q3 2025 per GNPX's latest filing, down from $3.8 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $51.0 million in Q1 2021 and bottomed at $3.6 million in Q3 2025.
  • Average Liabilities and Shareholders Equity over 5 years is $22.4 million, with a median of $16.6 million recorded in 2023.
  • Peak YoY movement for Liabilities and Shareholders Equity: surged 107.13% in 2021, then tumbled 76.52% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $42.9 million in 2021, then plummeted by 41.48% to $25.1 million in 2022, then plummeted by 57.46% to $10.7 million in 2023, then tumbled by 61.35% to $4.1 million in 2024, then decreased by 13.62% to $3.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $3.6 million in Q3 2025, $3.8 million in Q2 2025, and $6.0 million in Q1 2025.